INOVIO PHARMACEUTICALS, INC.
Last · NASDAQ$0.986-0.014 (-1.40%)close · yahoo · 18h ago
Market cap$101.95M103.4M sh
P/E · TTM-1.1fwd -2.2 · eps -0.90 · loss
Beta1.61vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.56$2.72
Volume3.0Msession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-12
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 5747.8%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -130000.0%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -135637.2%
- Cash Runway Low — Cash runway ~0.5 years
- Accumulated Deficit High — Accumulated deficit / equity 7533%
- Rd Intensity High — R&D/Revenue 82957.4%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.20
Est. revenue
0
Earnings transcripts
Documents
FormReporting forFiledFlags